Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pomotrelvir (PBI-0451) is a selective, orally administered inhibitor of the SARS-CoV-2 3CL protease with antiviral properties, making it suitable for novel coronavirus (COVID-19) research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | 6-8 weeks | |
50 mg | $2,180 | 6-8 weeks | |
100 mg | $2,800 | 6-8 weeks |
Description | Pomotrelvir (PBI-0451) is a selective, orally administered inhibitor of the SARS-CoV-2 3CL protease with antiviral properties, making it suitable for novel coronavirus (COVID-19) research. |
Alias | PBI-0451 |
Molecular Weight | 455.94 |
Formula | C23H26ClN5O3 |
Cas No. | 2713437-86-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.